Entrar Registro gratuito

Telesis Bio Inc Venda descoberta % de circulação

Qual é o Venda descoberta % de circulação de Telesis Bio Inc?

O Venda descoberta % de circulação de Telesis Bio Inc é 12.87%

Qual é a definição de Venda descoberta % de circulação?



Porcentagem de venda de ações descobertas em circulação é a quantidade de ações que estão sendo vendidas descobertas comparada com a circulação de ações totais, expressa como uma porcentagem.

Short percentage of float, or short interest ratio, is calculated by taking the total amount of shares shorted and dividing it by the total amount of shares available for trade. It is an indirect metric of investor sentiment. When short percentage of float is high, above 40%, it implies company investors hope shares will decline in value. The percentage is used by both fundamental and technical traders to identify trends. The short percentage of float can also be calculated for entire exchanges to determine the sentiment of the market as a whole. If it is high of around five or greater for an exchange, this can be taken as a bearish signal, and vice versa.

Venda descoberta % de circulação de empresas na Setor Health Care em NASDAQ em comparação com Telesis Bio Inc

O que Telesis Bio Inc faz?

sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.

Empresas com venda descoberta % de circulação semelhantes a Telesis Bio Inc